#16OF 25
↗
Company profileavernatx.com ↗
Averna Therapeutics
Averna Therapeutics develops RNA- and lipid nanoparticle-based genomic medicines.
- Headquarters
- United StatesSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 11 to 50Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 4 supported appearances ↗Source: RevenueBase lists
What does Averna Therapeutics do?
Its technology inserts therapeutic genetic instructions into genomic “safe harbor” sites. The described sites allow stable gene integration without disrupting normal cell function.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
#17OF 25
↗#17OF 25
↗#25OF 25
↗Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
BADGE PREVIEW
Open the published source list.
Open the published source list.Company information
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.
Help keep this profile accurate
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Find your next account
Explore company profiles →One company is just the start.
Explore more companies by name, headquarters and business focus.